Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.69, $0.02 better than the analyst estimate of $0.67. Revenue for the quarter came in at $305 million versus the consensus estimate of $311.96 million.

GUIDANCE:

Dolby Laboratories sees Q4 2026 EPS of $1.13-$1.28, versus the consensus of $1.21. Dolby Laboratories sees Q4 2026 revenue of $362-392 million, versus the consensus of $351.9 million.

Dolby Laboratories sees FY2026 EPS of $4.25-$4.40, versus the consensus of $4.32. Dolby Laboratories sees FY2026 revenue of $1.41-1.44 billion, versus the consensus of $1.41 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.